Effects of growth hormone therapy on bone density and fracture risk in age-related osteoporosis in the absence of growth hormone deficiency: a systematic review and meta-analysis.

Abstract

PURPOSE:

In adults, growth hormone deficiency (GHD) has been associated with low bone mineral density (BMD), an effect counteracted by growth hormone (GH) replacement. Whether GH is beneficial in adults with age-related bone loss and without hypopituitarism is unclear.

METHODS:

We conducted a systematic literature search using Medline, Embase and the Cochrane Register of Controlled Trials. We extracted and analyzed data according to the bone outcome included [bone mineral content (BMC), BMD, and bone biomarker, fracture risk]. We performed a meta-analysis when possible.

RESULTS:

We included eight studies. Seven randomized 272 post-menopausal women, 61-69 years, to GH or control, for 6-24 months, and the eighth was an extension trial. Except for one study, all women received concurrent osteoporosis therapies. There was no significant effect of GH, as compared to control, on BMD at the lumbar spine (Weighted mean difference WMD = -0.01 [-0.04, 0.02]), total hip (WMD = 0 [-0.05, 0.06]) or femoral neck (WMD = 0 [-0.03, 0.04]). Similarly, no effect was seen on BMC. GH significantly increased the bone formation marker procollagen type-I carboxy-terminal propeptide (PICP) (WMD = 14.03 [2.68, 25.38]). GH resulted in a trend for increase in osteocalcin and in bone resorption markers. Patients who received GH had a significant decrease in fracture risk as compared to control (RR = 0.63 [0.46, 0.87]). Reported adverse events were not major, mostly related to fluid retention.

CONCLUSION:

GH may not improve bone density in women with age-related bone loss but may decrease fracture risk. Larger studies of longer duration are needed to further explore these findings in both genders, and to investigate the effect of GH on bone quality.

• Authors: Maya Barake, Asma Arabi, Nancy Nakhoul, Ghada El-Hajj Fuleihan, Sarah El Ghandour, Anne Klibanski, Nicholas A Tritos
• Journal: Endocrine (Endocrine) Vol. 59 Issue 1 Pg. 39-49 (01 2018) ISSN: 1559-0100 [Electronic] United States
• PMID: 29030774 (Publication Type: Journal Article, Meta-Analysis, Review, Systematic Review)

Chemical References

• Human Growth Hormone

Topics

• Aged
• Bone Density (drug effects)
• Female
• Fractures, Bone (epidemiology, prevention & control)
• Hormone Replacement Therapy
• Human Growth Hormone (deficiency, pharmacology)
• Humans
• Hypopituitarism (complications, drug therapy)
• Middle Aged
• Osteoporosis (complications, drug therapy, epidemiology)
• Osteoporotic Fractures (epidemiology, etiology, prevention & control)
• Randomized Controlled Trials as Topic (statistics & numerical data)
• Risk Factors